The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.31

Today's change+0.29 +2.23%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.31

Today's change+0.29 +2.23%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc crosses above 20-day moving average

Allscripts Healthcare Solutions Inc closed up sharply Friday, rallying (U.S.)$0.29 or 2.23% to (U.S.)$13.31 and crossing above its 20-day moving average. Over the last five days, shares have gained 1.45%, but are down 13.46% for the last year to date. Shares have underperformed the S&P 500 by 6.36% during the last year.

Key company metrics

  • Open(U.S.) $12.99
  • Previous close(U.S.) $13.02
  • High(U.S.) $13.33
  • Low(U.S.) $12.99
  • Bid / Ask(U.S.) $11.04 / (U.S.) $15.00
  • YTD % change-13.46%
  • Volume2,074,964
  • Average volume (10-day)1,990,564
  • Average volume (1-month)1,879,551
  • Average volume (3-month)2,413,702
  • 52-week range(U.S.) $11.47 to (U.S.) $15.78
  • Beta1.00
  • Trailing P/E258.20×
  • P/E 1 year forward22.67×
  • Forward PEG0.42×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.05
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue346346354352
Total other revenue--------
Total revenue346346354352
Gross profit152154153144
Total cost of revenue194192201208
Total operating expense334323346346
Selling / general / administrative84799187
Research & development47464844
Depreciation / amortization4467
Interest expense (income), net operating--------
Unusual expense (income)5100
Other operating expenses, total--------
Operating income122396
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax315-1-2
Income after tax216-5-3
Income tax, total1-241
Net income216-5-3
Total adjustments to net income--------
Net income before extra. items216-5-3
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items216-5-3
Inc. avail. to common incl. extra. items216-5-3
Diluted net income216-5-3
Dilution adjustment0------
Diluted weighted average shares191189189182
Diluted EPS excluding extraordinary itemsvalue per share0.010.09-0.03-0.02
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.030.09-0.03-0.02
R